Login / Signup

Effectiveness of Dalbavancin Compared With Standard of Care for the Treatment of Osteomyelitis: A Real-world Analysis.

Alexander R CainDerek N BremmerDustin R CarrCarley BuchananMax JacobsThomas L WalshMatthew A MoffaNathan R ShivelyTamara L Trienski
Published in: Open forum infectious diseases (2021)
Dalbavancin administered as a 2-dose regimen is a safe and effective option for the treatment of osteomyelitis.
Keyphrases
  • healthcare
  • randomized controlled trial
  • systematic review
  • palliative care
  • quality improvement